These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37073790)

  • 1. Online monitoring of focal spasticity treatment with botulinum toxin in people with chronic stroke or hereditary spastic paraplegia: a feasibility study.
    Kerstens HCJW; Nijkrake MJ; De Swart BJM; Nijhuis-van der Sanden RWG; Vos-van de Hulst M; Bos GJ; Geurts ACH; Van der Wees PJ
    J Rehabil Med; 2023 Apr; 55():jrm00383. PubMed ID: 37073790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional effects of botulinum toxin type-A treatment and subsequent stretching of spastic calf muscles: a study in patients with hereditary spastic paraplegia.
    de Niet M; de Bot ST; van de Warrenburg BP; Weerdesteyn V; Geurts AC
    J Rehabil Med; 2015 Feb; 47(2):147-53. PubMed ID: 25325386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of botulinum toxin type A in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia.
    van Lith BJH; den Boer J; van de Warrenburg BPC; Weerdesteyn V; Geurts AC
    J Rehabil Med; 2019 Jun; 51(6):434-441. PubMed ID: 30968942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of therapeutic ultrasound and transcutaneous electrical nerve stimulation compared with botulinum toxin type A in the treatment of spastic equinus in adults with chronic stroke: a pilot randomized controlled trial.
    Picelli A; Dambruoso F; Bronzato M; Barausse M; Gandolfi M; Smania N
    Top Stroke Rehabil; 2014; 21 Suppl 1():S8-16. PubMed ID: 24722047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.
    Diniz de Lima F; Faber I; Servelhere KR; Bittar MFR; Martinez ARM; Piovesana LG; Martins MP; Martins CR; Benaglia T; de Sá Carvalho B; Nucci A; França MC
    Mov Disord; 2021 Jul; 36(7):1654-1663. PubMed ID: 33595142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experienced consequences of spasticity and effects of botulinum toxin injections: a qualitative study amongst patients with disabling spasticity after stroke.
    Kerstens HCJW; Satink T; Nijkrake MJ; De Swart BJM; Nijhuis-van der Sanden MWG; Van der Wees PJ; Geurts ACH
    Disabil Rehabil; 2021 Dec; 43(25):3688-3695. PubMed ID: 32255361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.
    Chen YT; Zhang C; Liu Y; Magat E; Verduzco-Gutierrez M; Francisco GE; Zhou P; Zhang Y; Li S
    Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study.
    Baricich A; Picelli A; Carda S; Smania N; Cisari C; Santamato A; de Sire A; Invernizzi M
    Ann Phys Rehabil Med; 2019 Jul; 62(4):214-219. PubMed ID: 31228593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of robot‑assisted gait training and botulinum toxin type A on spastic equinus foot in patients with chronic stroke: a pilot, single blind, randomized controlled trial.
    Picelli A; Bacciga M; Melotti C; LA Marchina E; Verzini E; Ferrari F; Pontillo A; Corradi J; Tamburin S; Saltuari L; Corradini C; Waldner A; Smania N
    Eur J Phys Rehabil Med; 2016 Dec; 52(6):759-766. PubMed ID: 27098300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound Elastography to Assess Botulinum Toxin A Treatment for Post-stroke Spasticity: A Feasibility Study.
    Gao J; Rubin JM; Chen J; O'Dell M
    Ultrasound Med Biol; 2019 May; 45(5):1094-1102. PubMed ID: 30898386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
    Hara T; Abo M; Hara H; Kobayashi K; Shimamoto Y; Shibata Y; Sasaki N; Yamada N; Niimi M
    Int J Neurosci; 2018 May; 128(5):412-420. PubMed ID: 28985683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations.
    Servelhere KR; Faber I; Martinez A; Nickel R; Moro A; Germiniani FMB; Moscovich M; Blume TR; Munhoz RP; Teive HAG; França MC
    Arq Neuropsiquiatr; 2018 Mar; 76(3):183-188. PubMed ID: 29809239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
    Bensmail D; Hanschmann A; Wissel J
    J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stumbling, struggling, and shame due to spasticity: a qualitative study of adult persons with hereditary spastic paraplegia.
    Kerstens HCJW; Satink T; Nijkrake MJ; De Swart BJM; Van Lith BJH; Geurts ACH; Nijhuis-van der Sanden MWG
    Disabil Rehabil; 2020 Dec; 42(26):3744-3751. PubMed ID: 31079503
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia-The SPASTOX Trial.
    Nonnekes J; Geurts A
    Mov Disord; 2021 Jul; 36(7):1733. PubMed ID: 34302383
    [No Abstract]   [Full Text] [Related]  

  • 19. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
    Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S
    Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.